Why Did Seeing Machines Limited Soar On Samsung Deal?

Why the Samsung Electronics Co Ltd (ADR) (LON:BC94) deal is so important for Seeing Machines Limited (LON:SEE).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

opencast.miningAustralian eye-tracking technology company Seeing Machines Limited (LSE: SEE) climbed more than 10% this morning, after the company announced a new memorandum of understanding with Samsung Electro-Mechanics Corporation (SEMCo).

It’s the second new strategic partnership this month for Seeing Machines, following news of a 15-year agreement with a subsidiary of Takata Corporation — a company that makes automotive safety systems — earlier this month.

Why does it matter?

Seeing Machines biggest customer to date, Caterpillar, is making very successful use of the firm’s eye-tracking technology in its large mining machines, where driver fatigue is a real problem — and the human and financial costs of a moment’s drowsiness can be massive.

The firm’s deal with Takata is a logical extension of this, as many road accidents are also caused by tiredness.

However, today’s deal with Samsung opens up a whole new potential market to Seeing Machines: the consumer electronics industry is massive, and eye-tracking is likely to be one of the key elements of next-generation user interfaces.

Is Seeing Machines a buy?

Seeing Machines isn’t the kind of investment we’d normally discuss in-depth here at the Motley Fool — it’s a loss-making, early-stage technology company.

However, there’s an exception to every rule, and I believe that Seeing Machines is worth serious consideration for growth investors with a longish horizon.

Here’s why:

1. World-class partners

I’m not a world-class expert on Seeing Machines’ technology, but some of the world’s leading industrial names — such as Caterpillar and Samsung — are experts, and are seriously enthusiastic about Seeing Machines.

2. Use your imagination

The potential market for driver fatigue monitoring systems alone is huge.

It’s not hard to imagine this kind of technology being standard fitment in all new cars, trains, buses, lorries, aeroplanes and industrial plant, 10-15 years from now.

I suspect that the cost of the new technology would largely pay for itself in terms of accident reduction.

3. Cash in hand

Although Seeing Machines is currently loss-making, the firm has £15m of cash on hand — equivalent to a quarter of its market cap — and revenues are expected to double in 2015.

In my view, the technology is highly commercial, and Seeing Machines is a sector leader — so at some point, profits — or a takeover deal — are likely to follow the firm’s rising revenues.

Buy today?

Seeing Machines isn’t dirt cheap at today’s 7.6p share price, and it’s possible that the market will provide better buying opportunities in the weeks and months ahead. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland does not own shares in any of the companies mentioned.

More on Investing Articles

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »